Cancer metastasis—the spread of cancer to other organs—is the leading cause of death among cancer patients. Researchers have ...

This strategic alliance brings together the longstanding oncology diagnostic experience of Myriad Genetics and the clinical and translational research expertise of MD Anderson to create a portfolio of ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

An AI foundation model capable of predicting gene activity across many different human cell types may expedite research for ...

The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad's molecular ...

The field of cancer research is beginning to embrace a broader perspective that goes beyond genetic and molecular studies, recognizing the significant role ...

Cancer metastasis-the spread of cancer to other organs-is the leading cause of death among cancer patients. Researchers have now uncovered a "genetic signature" of 177 genes shared across multiple ...

Cancer metastasis -- the spread of cancer to other organs -- is the leading cause of death among cancer patients. Researchers have now uncovered a 'genetic signature' of 177 genes shared across ...

Over the past two decades, advances in the molecular genetics of MFS have enhanced our understanding, making FBN1 molecular testing essential in the clinical management of MFS and related connective ...

A variant of PCSK9, a gene involved in raising cholesterol, may spur metastasis. An approved antibody might stop it.